All data are shown in Table 1, including age, gender, menopause status, histological type, T classification, N classification, M classification, TNM stage, molecular subtype, ER, PR, HER-2, margin status, vital status, radiation therapy, neoadjuvant treatment, targeted molecular therapy, sample type, OS, RFS and ZNF385B expression of BC. Here, ERBB2 is linked to breast cancer.